Sector valuations GC Genome Corporation
Stocks
A340450
KR7340450006
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,450.00 KRW | -6.71% |
|
-8.44% | -34.75% |
| 12-09 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 12/06/25 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 1.37x | - | 13.35x | - | 75.13M | ||
| -162.47x | 20.68x | -17.44x | 13.45x | -183.51x | -148.58x | -.--% | 38.66B | ||
| 19.1x | 2.41x | 0.5x | 1.86x | 10.7x | 12.64x | 1.05% | 22.7B | ||
| 17.02x | 1.2x | 1x | 1.33x | 7.56x | 13.81x | 5.11% | 7.3B | ||
| 336.41x | - | -1.89x | - | - | - | - | 5.16B | ||
| 48.03x | 9.99x | 3.01x | 8.54x | 30.33x | 37.85x | 1.08% | 2.97B | ||
| -21.9x | - | -0.07x | - | - | - | - | 1.95B | ||
| 32.09x | 1.89x | 0.04x | 1.15x | 9.57x | 13.97x | 0.79% | 1.84B | ||
| -31.66x | - | 0.67x | - | - | - | -.--% | 1.84B | ||
| 12.91x | 1.72x | 0.95x | 1.34x | 5.24x | 8.94x | 5.86% | 1.75B | ||
| 33.73x | 1.64x | -0.11x | 1.47x | 11.98x | 20.45x | 1.6% | 1.68B | ||
| 83.43x | 14.99x | 4.25x | 17.38x | 42.91x | 58.5x | 0.12% | 1.5B | ||
| 58.84x | 8.11x | 1.58x | 7.04x | 29.06x | 42.02x | 0.36% | 1.23B | ||
| 32.88x | 1.38x | -2.14x | 0.81x | 6.69x | 22.88x | 3.7% | 1.15B | ||
| -4.46x | 0.59x | -4.47x | 1.17x | - | -2.97x | - | 1.02B | ||
| 41.8x | 12.86x | 2.04x | - | - | - | 2.09% | 861M | ||
| 18.19x | 1.05x | -14.29x | - | - | - | 3.42% | 848M | ||
| 25.5x | 1.92x | 1x | - | - | - | 0.38% | 784M | ||
| -46.28x | - | 1.55x | 196.9x | -42.95x | -40.78x | - | 641M | ||
| Average | 27.40x | 5.75x | -1.32x | 19.52x | -6.58x | 4.01x | 1.83% | 4.95B | |
| Weighted average by Cap. | -37.66x | 11.27x | -7.04x | 9.30x | -80.80x | -60.97x | 1.04% |
- Stock Market
- Stocks
- A340450 Stock
- Sector GC Genome Corporation
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















